290 related articles for article (PubMed ID: 8824592)
1. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
[TBL] [Abstract][Full Text] [Related]
2. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL; Zhu AQ; Singh H
EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.
Ortiz MA; Light J; Maki RA; Assa-Munt N
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2740-5. PubMed ID: 10077581
[TBL] [Abstract][Full Text] [Related]
4. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis CF; Singh H; Storb U
Genes Dev; 1995 Jun; 9(11):1377-87. PubMed ID: 7797077
[TBL] [Abstract][Full Text] [Related]
5. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.
Meraro D; Gleit-Kielmanowicz M; Hauser H; Levi BZ
J Immunol; 2002 Jun; 168(12):6224-31. PubMed ID: 12055236
[TBL] [Abstract][Full Text] [Related]
6. SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus.
Carlsson R; Persson C; Leanderson T
Mol Immunol; 2003 Jun; 39(16):1035-43. PubMed ID: 12749910
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of PU.1/IRF-4/DNA ternary complex.
Escalante CR; Brass AL; Pongubala JM; Shatova E; Shen L; Singh H; Aggarwal AK
Mol Cell; 2002 Nov; 10(5):1097-105. PubMed ID: 12453417
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
9. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
[TBL] [Abstract][Full Text] [Related]
10. Pub, a novel PU.1 binding protein, regulates the transcriptional activity of PU.1.
Hirose S; Nishizumi H; Sakano H
Biochem Biophys Res Commun; 2003 Nov; 311(2):351-60. PubMed ID: 14592421
[TBL] [Abstract][Full Text] [Related]
11. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
Marecki S; Riendeau CJ; Liang MD; Fenton MJ
J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
[TBL] [Abstract][Full Text] [Related]
12. Analysis of PU.1/ICSBP (IRF-8) complex formation with various PU.1 mutants: molecular cloning of rat Icsbp (Irf-8) cDNA.
Nakano N; Nishiyama C; Masuoka N; Nishiyama M; Yamane H; Okumura K; Ogawa H
Immunogenetics; 2005 Mar; 56(12):871-7. PubMed ID: 15688197
[TBL] [Abstract][Full Text] [Related]
13. PU.1/Interferon Regulatory Factor interactions: mechanisms of transcriptional regulation.
Marecki S; Fenton MJ
Cell Biochem Biophys; 2000; 33(2):127-48. PubMed ID: 11325034
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha is stimulated by 12-O-tetradecanoyl phorbol-13-acetate through IRF/ISRE binding motifs.
Yu F; Wang Q; Floyd-Smith G
Gene; 1999 Sep; 237(1):177-84. PubMed ID: 10524248
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
16. A two-step mechanism for recruitment of Pip by PU.1.
Perkel JM; Atchison ML
J Immunol; 1998 Jan; 160(1):241-52. PubMed ID: 9551977
[TBL] [Abstract][Full Text] [Related]
17. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex.
Kanno Y; Levi BZ; Tamura T; Ozato K
J Interferon Cytokine Res; 2005 Dec; 25(12):770-9. PubMed ID: 16375605
[TBL] [Abstract][Full Text] [Related]
18. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
19. Protein-protein and DNA-protein interactions affect the activity of lymphoid-specific IFN regulatory factors.
Meraro D; Hashmueli S; Koren B; Azriel A; Oumard A; Kirchhoff S; Hauser H; Nagulapalli S; Atchison ML; Levi BZ
J Immunol; 1999 Dec; 163(12):6468-78. PubMed ID: 10586038
[TBL] [Abstract][Full Text] [Related]
20. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors.
Sharf R; Azriel A; Lejbkowicz F; Winograd SS; Ehrlich R; Levi BZ
J Biol Chem; 1995 Jun; 270(22):13063-9. PubMed ID: 7768900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
